InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.91
(
-1.01%
)
US TECH 100
19,661.20
(
-2.27%
)
Dow Jones
39,774.86
(
0.13%
)
Brent Oil
84.93
(
-0.15%
)
Bitcoin
57,771.09
(
0.02%
)
Post# of 252571
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120028
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 246620

Thursday, 05/04/2023 11:13:07 AM

Thursday, May 04, 2023 11:13:07 AM

Post# of 252571
NVO’s 1Q23 obesity sales=$1.15B, +124% YoY in constant currency:

https://www.globenewswire.com/news-release/2023/05/04/2661062/0/en/Novo-Nordisk-s-sales-increased-by-27-in-Danish-kroner-and-by-25-at-constant-exchange-rates-to-DKK-53-4-billion-in-the-first-three-months-of-2023.html

1Q23 Wegovy sales would have been even higher if not for constrained manufacturing. In Apr 2023, a second CRO began production of Wegovy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up